Shanghai Guosheng Haitong Private Enterprise High-Quality Development Private Investment Fund and Shanghai Guosheng Capital Management Co., Ltd. entered into 5.0017% stake in Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) from Wang Huiying for CNY 322.875 million on July 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.5 CNY | -1.71% | -6.23% | -17.90% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.90% | 875M | |
+37.78% | 723B | |
+32.82% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.64% | 244B | |
-4.13% | 208B | |
+10.63% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Shanghai Guosheng Haitong Private Enterprise High-Quality Development Private Investment Fund and Shanghai Guosheng Capital Management Co., Ltd. entered into 5.0017% stake in Guizhou Sanli Pharmaceutical Co.,Ltd from Wang Huiying for CNY 322.875 million.